Takhzyro
lanadelumab-flyo · Solution · Subcutaneous
No FDA structured label text is available for Takhzyro. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Lanadelumab in 2 products
Takhzyro NDC products (2)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 47783-645 | Lanadelumab 150 mg/mL Solution | Takeda Pharmaceuticals America, Inc. | BLA |
| 47783-646 | Lanadelumab 300 mg/2mL Solution | Takeda Pharmaceuticals America, Inc. | BLA |
Frequently asked questions
Who makes Takhzyro?
Takhzyro is listed by 1 labeler in the FDA NDC directory, including Takeda Pharmaceuticals America, Inc..